Empreendimentos Pague Menos S.A.

BVMF-PGMN3
Brazil Stock Exchange
Healthcare Pharmaceutical Retailers
Global Rank
#16014
Country Rank
#152
Market Cap
403.58 M
Price
0.651
Change (%)
2.72%
Volume
570,800

BVMF-PGMN3's Next Dividend

Next Estimated Amount
R$0.215
Next Estimated Pay Date
02/20/2026
Last Amount
R$0.215
Last Pay Date
02/27/2025
Dividend Shot Clock Ex-Date: 01/21/2025
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Empreendimentos Pague Menos S.A. Dividend Chart

*Amounts are shown in the stock exchange currency (BRL) for convenience

Empreendimentos Pague Menos S.A.(BVMF-PGMN3) Dividend History

Empreendimentos Pague Menos S.A. (BVMF-PGMN3) currently pays an annual dividend of $0.22 per share, offering a dividend yield of 6.87%. The next dividend payout date has not been announced.
Ex-Dividend Date Amount Adj. Amount Dividend Yield Pay Date Change (%)
2025 R$0.215 R$0.215 -14%
01/21/2025 R$0.215 R$0.215 n/a 02/27/2025 -14%
2024 R$0.251 R$0.251 59%
01/29/2024 R$0.251 R$0.251 n/a 03/06/2024 59%
2023 R$0.158 R$0.158
01/30/2023 R$0.158 R$0.158 n/a 03/13/2023
*Amounts are shown in the stock exchange currency (BRL) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.